Omega Design Corporation Introduces LabelSync 450 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Omega Design Corporation Introduces LabelSync 450

Pharmaceutical Technology
Volume 37, Issue 9, pp. 14
Omega LabelSync 450

Omega Design Corporation offers the LabelSync 450 Vision Module, designed to capture and sync a bottle’s unique serialized label with its individual line code. The machine can handle bottles 30-1500 mL in volume at speeds up to 300 per minute. Compatible with a range of serialization software and vision components, the LabelSync 450 verifies each code’s readability, confirms that each bottle belongs on the line, establishes a one-to-one relationship between the two codes, and enables high-integrity identification processes downstream. The LabelSync 450’s vision system is comprised of four cameras whose combined viewpoints offer 360-degree label inspection, as well as a fifth camera to read secondary line code.

Omega Design Corporation

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
8%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Pharmaceutical Technology,
Click here